| Date Filed | Type | Description |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| Hindman James M. (Director) has filed a Form 4 on ACCURAY INC|
Txns:
| Granted 33,632 shares
@ $0 |
|
| 07/23/2020 |
4
| Hindman James M. (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Hindman James M. (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 61,000 options to buy
@ $10.53, valued at
$642.3k
|
|
| 06/01/2020 |
3
| Hindman James M. (Director) has filed a Form 3 on Urovant Sciences Ltd. |
| 12/03/2019 |
4
| Hindman James M. (Director) has filed a Form 4 on ACCURAY INC|
Txns:
| Granted 9,025 shares
@ $0
Granted 48,701 shares
@ $0 |
|
| 09/16/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/21/2019 |
4
| Hindman James M. (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $11.59, valued at
$139.1k
|
|
| 06/03/2019 |
4
| Hindman James M. (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 01/17/2019 |
4
| Hindman James M. (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 6,000 options to buy
@ $8.8, valued at
$52.8k
|
|
| 12/11/2018 |
4
| Hindman James M. (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 17,509 options to buy
@ $6.59, valued at
$115.4k
Granted 3,720 options to buy
@ $16.4, valued at
$61k
|
|
| 12/11/2018 |
3
| Hindman James M. (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
| 08/03/2018 |
4
| Hindman James M. (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $15.15, valued at
$303k
|
|
| 08/03/2018 |
3
| Hindman James M. (Director) has filed a Form 3 on Sienna Biopharmaceuticals, Inc. |